Liraglutide improves lipid metabolism by enhancing cholesterol efflux associated with ABCA1 and ERK1/2 pathway

BACKGROUND: Reverse cholesterol transport (RCT) is an important cardioprotective mechanism and the decrease in cholesterol efflux can result in the dyslipidemia. Although liraglutide, a glucagon like peptide-1 analogue, has mainly impacted blood glucose, recent data has also suggested a beneficial e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ya-Ru, Shi, Xiao-Yun, Ma, Chun-Yan, Zhang, Yue, Xu, Rui-Xia, Li, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842145/
https://www.ncbi.nlm.nih.gov/pubmed/31706303
http://dx.doi.org/10.1186/s12933-019-0954-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842145/
https://www.ncbi.nlm.nih.gov/pubmed/31706303
http://dx.doi.org/10.1186/s12933-019-0954-6

Ejemplares similares